338 related articles for article (PubMed ID: 11181646)
1. Surfactant proteins A and D protect mice against pulmonary hypersensitivity induced by Aspergillus fumigatus antigens and allergens.
Madan T; Kishore U; Singh M; Strong P; Clark H; Hussain EM; Reid KB; Sarma PU
J Clin Invest; 2001 Feb; 107(4):467-75. PubMed ID: 11181646
[TBL] [Abstract][Full Text] [Related]
2. Surfactant protein D inhibits early airway response in Aspergillus fumigatus-sensitized mice.
Erpenbeck VJ; Ziegert M; Cavalet-Blanco D; Martin C; Baelder R; Glaab T; Braun A; Steinhilber W; Luettig B; Uhlig S; Hoymann HG; Krug N; Hohlfeld JM
Clin Exp Allergy; 2006 Jul; 36(7):930-40. PubMed ID: 16839409
[TBL] [Abstract][Full Text] [Related]
3. Lung surfactant proteins A and D can inhibit specific IgE binding to the allergens of Aspergillus fumigatus and block allergen-induced histamine release from human basophils.
Madan T; Kishore U; Shah A; Eggleton P; Strong P; Wang JY; Aggrawal SS; Sarma PU; Reid KB
Clin Exp Immunol; 1997 Nov; 110(2):241-9. PubMed ID: 9367408
[TBL] [Abstract][Full Text] [Related]
4. Susceptibility of mice genetically deficient in the surfactant protein (SP)-A or SP-D gene to pulmonary hypersensitivity induced by antigens and allergens of Aspergillus fumigatus.
Madan T; Reid KB; Singh M; Sarma PU; Kishore U
J Immunol; 2005 Jun; 174(11):6943-54. PubMed ID: 15905537
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic effects of recombinant forms of full-length and truncated human surfactant protein D in a murine model of invasive pulmonary aspergillosis.
Singh M; Madan T; Waters P; Sonar S; Singh SK; Kamran MF; Bernal AL; Sarma PU; Singh VK; Crouch EC; Kishore U
Mol Immunol; 2009 Jul; 46(11-12):2363-9. PubMed ID: 19403176
[TBL] [Abstract][Full Text] [Related]
6. Immunology of allergic bronchopulmonary aspergillosis.
Kurup VP
Indian J Chest Dis Allied Sci; 2000; 42(4):225-37. PubMed ID: 15597669
[TBL] [Abstract][Full Text] [Related]
7. Intranasal delivery of a truncated recombinant human SP-D is effective at down-regulating allergic hypersensitivity in mice sensitized to allergens of Aspergillus fumigatus.
Strong P; Reid KB; Clark H
Clin Exp Immunol; 2002 Oct; 130(1):19-24. PubMed ID: 12296848
[TBL] [Abstract][Full Text] [Related]
8. Protective roles of pulmonary surfactant proteins, SP-A and SP-D, against lung allergy and infection caused by Aspergillus fumigatus.
Kishor U; Madan T; Sarma PU; Singh M; Urban BC; Reid KB
Immunobiology; 2002 Sep; 205(4-5):610-8. PubMed ID: 12396019
[TBL] [Abstract][Full Text] [Related]
9. Allergic bronchopulmonary mycosis complicating cystic fibrosis.
Knutsen A; Slavin RG
Semin Respir Infect; 1992 Sep; 7(3):179-92. PubMed ID: 1475542
[TBL] [Abstract][Full Text] [Related]
10. Identification of novel allergens of Aspergillus fumigatus using immunoproteomics approach.
Gautam P; Sundaram CS; Madan T; Gade WN; Shah A; Sirdeshmukh R; Sarma PU
Clin Exp Allergy; 2007 Aug; 37(8):1239-49. PubMed ID: 17651155
[TBL] [Abstract][Full Text] [Related]
11. Protective effects of a recombinant fragment of human surfactant protein D in a murine model of pulmonary hypersensitivity induced by dust mite allergens.
Singh M; Madan T; Waters P; Parida SK; Sarma PU; Kishore U
Immunol Lett; 2003 May; 86(3):299-307. PubMed ID: 12706535
[TBL] [Abstract][Full Text] [Related]
12. Protective role of lung surfactant protein D in a murine model of invasive pulmonary aspergillosis.
Madan T; Kishore U; Singh M; Strong P; Hussain EM; Reid KB; Sarma PU
Infect Immun; 2001 Apr; 69(4):2728-31. PubMed ID: 11254642
[TBL] [Abstract][Full Text] [Related]
13. Engineered recombinant ovomucoid third domain can modulate allergenic response in Balb/c mice model.
Rupa P; Mine Y
Biochem Biophys Res Commun; 2006 Apr; 342(3):710-7. PubMed ID: 16494843
[TBL] [Abstract][Full Text] [Related]
14. The costimulatory molecules CD80, CD86 and OX40L are up-regulated in Aspergillus fumigatus sensitized mice.
Barrios CS; Johnson BD; D Henderson J; Fink JN; Kelly KJ; Kurup VP
Clin Exp Immunol; 2005 Nov; 142(2):242-50. PubMed ID: 16232210
[TBL] [Abstract][Full Text] [Related]
15. Time course of antibody response to recombinant Aspergillus fumigatus antigens in cystic fibrosis with and without ABPA.
Casaulta C; Flückiger S; Crameri R; Blaser K; Schoeni MH
Pediatr Allergy Immunol; 2005 May; 16(3):217-25. PubMed ID: 15853950
[TBL] [Abstract][Full Text] [Related]
16. Modulation of airway inflammation by immunostimulatory CpG oligodeoxynucleotides in a murine model of allergic aspergillosis.
Banerjee B; Kelly KJ; Fink JN; Henderson JD; Bansal NK; Kurup VP
Infect Immun; 2004 Oct; 72(10):6087-94. PubMed ID: 15385513
[TBL] [Abstract][Full Text] [Related]
17. Surfactant protein d expression in chronic rhinosinusitis patients and immune responses in vitro to Aspergillus and alternaria in a nasal explant model.
Ooi EH; Wormald PJ; Carney AS; James CL; Tan LW
Laryngoscope; 2007 Jan; 117(1):51-7. PubMed ID: 17202930
[TBL] [Abstract][Full Text] [Related]
18. Pneumocystis carinii pneumonia alters expression and distribution of lung collectins SP-A and SP-D.
Atochina EN; Beck JM; Scanlon ST; Preston AM; Beers MF
J Lab Clin Med; 2001 Jun; 137(6):429-39. PubMed ID: 11385364
[TBL] [Abstract][Full Text] [Related]
19. IgE down regulation and cytokine induction by Aspergillus antigens in human allergic bronchopulmonary aspergillosis.
Murali PS; Kurup VP; Bansal NK; Fink JN; Greenberger PA
J Lab Clin Med; 1998 Mar; 131(3):228-35. PubMed ID: 9523846
[TBL] [Abstract][Full Text] [Related]
20. A murine model of allergic bronchopulmonary aspergillosis with elevated eosinophils and IgE.
Kurup VP; Mauze S; Choi H; Seymour BW; Coffman RL
J Immunol; 1992 Jun; 148(12):3783-8. PubMed ID: 1602128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
